Navigation Links
Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
Date:1/19/2009

A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

VOORHEES, N.J., Jan. 19 /PRNewswire/ -- Clostridium difficile infection (CDI) is increasingly being seen in older adults, especially among residents of long-term care facilities (LTCFs). This is further complicated by the emergence of a virulent strain of C. difficile associated with high rates of morbidity and mortality.

Implementing strategies for prevention and control, early diagnosis and prompt aggressive treatment is critical in managing CDI.

To address the need for current education on CDI, especially among healthcare professionals working in LTCFs, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education Medscape virtual lecture entitled, "Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management." This virtual lecture offers continuing education credit for physicians, pharmacists and registered nurses and is supported by an educational grant from ViroPharma Incorporated.

Donald Kaye, MD, MACP, Professor of Medicine at Drexel University College of Medicine in Philadelphia, Pennsylvania, and Kurt B. Stevenson, MD, MPH, Associate Professor in Internal Medicine and Associate Director of Clinical Epidemiology at Ohio State University College of Medicine in Columbus, Ohio will serve as faculty for this activity.

Healthcare professionals can access the virtual lecture at http://cme.medscape.com/viewprogram/18692.

Healthcare professionals working in LTCFs should take advantage of this opportunity to learn important insights and guidelines for managing this rapidly changing disease.

"Robert Michael Educational Institute LLC recognizes that continuing education plays a crucial role in the provision of quality health care and is dedicated to offering professionals meaningful opportunities for lifelong learning," says President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited, and non-accredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
2. Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
3. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
4. National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks
5. APIC launches first national C. difficile prevalence study
6. APIC Launches First National C. Difficile Prevalence Study
7. Advances in C. difficile research
8. New Report Shows High C-difficile Infection Rates in U.S. Hospitals
9. MRSA and C. difficile Infections Reduced by 50% in Hospital Study
10. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
11. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... further expand its Portable, Continuous, Miniature, and Modular (PCMM) collaboration with Pfizer and ... POD-based Oral Solid Dosage line. The new PODs will provide tablet coating capability ...
(Date:9/25/2017)... ... 25, 2017 , ... Lean Management techniques applied to the ... First-Defect-Stop for laboratory weighing is designed to help laboratory personnel strengthen lab ... consequences on downstream processes. , If a problem is detected, the "First-Defect-Stop" procedure ...
(Date:9/25/2017)... ... , ... The Asset Tracking and Temperature monitoring system works in conjunction with ... bar code of the product and lot ID then scanning the HPP basket and ... automatically generated and exception alerts sent out to designated individuals. , "In recognizing the ...
(Date:9/25/2017)... ... September 25, 2017 , ... Earlypicker is expanding its offerings to ... for the hottest Korean cosmetics and fashion trends sweeping the nation. The decision to ... well-known for the great offerings that allow Koreans everywhere to look their best every ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Grandpa's Visit”: a tender and relatable ... with the others. “Grandpa's Visit” is the creation of published author, Beverly Brumfield, gifted ... much like the character in her book. She shares, “Mr. Rice is struggling to ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... 2017  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... that it will be participating in the Morgan Stanley ... Grand Hyatt hotel in New York.  Zimmer Biomet will ... Eastern Time. A live webcast of the ... website at http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... WILMINGTON, Del. , Sept. 6, 2017 NeuroRx, ... for Acute Suicidal Ideation and Behavior (ASIB), has been granted ... for its sequential therapy of NRX-100 (ketamine HCl) followed by ... patients in a pivotal trial of this sequential therapy targeting ... bipolar depression. 1 ...
Breaking Medicine Technology: